AI assistant
Sending…
Axil Brands, Inc. — Director's Dealing 2023
Apr 25, 2023
34664_dirs_2023-04-25_1f9510b6-41cf-47b1-833d-93bbb643799b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3/A — Form 3/A
Issuer: Reviv3 Procare Co (RVIV)
CIK: 0001718500
Period of Report: 2022-11-01
Reporting Person: Jain Meenu (Chief Financial Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 250000 | Indirect |
Footnotes
F1: On November 1, 2022, the reporting person filed a Form 3 which mistakenly reported that she directly owns 250,000 shares of the issuer's common stock. As reported in this amendment, the reporting person indirectly owns the 250,000 shares of the issuer's common stock through her family trust. The error with respect to the nature of the reporting person's ownership was carried forward in one subsequent Form 4.
More from Axil Brands, Inc.
Earnings Release
2026
Apr 8
Interim / Quarterly Report
2026
Apr 8
Director's Dealing
2026
Mar 4
Board/Management Information
2026
Jan 20
Director's Dealing
2026
Jan 20
Director's Dealing
2026
Jan 20
Director's Dealing
2026
Jan 20
Regulatory Filings
2026
Jan 8
Interim / Quarterly Report
2026
Jan 8
Declaration of Voting Results & Voting Rights Announcements
2025
Dec 17